Edwards Lifesciences Corp

EWNYSE · USD
86.29USD0.00 (+0.66%)
687

Edwards Lifesciences Corp (EW) Wheel Strategy

EW wheel strategy scan found 99 cash-secured put setups on the previous trading day. Probability of expiring worthless is above 50%. Annualized returns reach up to 30.4%.

Read more

Running a EW wheel strategy lets you generate consistent premium income on Edwards Lifesciences Corp while setting your own entry and exit prices on the underlying. Edwards Lifesciences Corp's wheel combines cash-secured puts and covered calls into a repeatable cycle: sell puts at strikes where you'd be happy to own EW, and if assigned, sell calls at strikes where you'd be happy to sell. Use our scanner to find the best EW wheel strategy setups in real time.

The wheel works best on liquid, high-quality names with stable fundamentals and active options markets — exactly the profile many large-cap leaders fit. The mechanics are simple: sell a cash-secured put on EW, collect premium, and either keep the premium if it expires worthless or take assignment at a discount to current price. Once assigned, sell covered calls against the shares to keep collecting premium until they're called away. Choosing the right strikes, expirations, and IV environment is what separates a profitable EW wheel from a losing one.

Edwards Lifesciences Corporation provides products and technologies for structural heart disease, and critical care and surgical monitoring in the United States, Europe, Japan, and internationally. It offers transcatheter heart valve replacement products for the minimally invasive replacement of heart valves; and transcatheter heart valve repair and replacement products to treat mitral and tricuspid valve diseases. The company also provides the PASCAL and Cardioband transcatheter valve repair systems for minimally-invasive therapy. In addition, it offers surgical structural heart solutions, such as aortic surgical valve under the INSPIRIS name; KONECT RESILIA, a pre-assembled aortic tissue valved conduit for patients who require replacement of the valve, root, and ascending aorta; and HARPOON Beating Heart Mitral Valve Repair System for patients with degenerative mitral regurgitation.

Further, the company provides critical care solutions, including advanced hemodynamic monitoring systems to measure a patient's heart function and fluid status in surgical and intensive care settings; and Acumen Hypotension Prediction Index software that alerts clinicians in advance of a patient developing dangerously low blood pressure. The company distributes its products through a direct sales force and independent distributors. Edwards Lifesciences Corporation was founded in 1958 and is headquartered in Irvine, California.

The difference between a wheel that compounds and one that bleeds comes down to strike selection, IV timing, and discipline on assignment. Our scanner handles the heavy lifting: it ranks every leg of the EW wheel strategy by delta, premium yield, IV rank, and days to expiration, so you can deploy capital where the math works. Build your EW wheel strategy on data, not gut feel — and let the options wheel do what it does best: pay you to wait.

Oct 16, 202687.50$1.55$1.75-0.392434%58.0%30.4%181
Nov 20, 202687.50$3.60$3.80-0.415934%55.1%26.9%17
Dec 18, 202687.50$3.90$4.35-0.418734%54.2%20.9%38
Nov 20, 202685.00$2.60$2.85-0.335934%65.0%20.7%154
Oct 16, 202685.00$0.85$1.05-0.262434%72.8%18.8%381
Jan 15, 202787.50$4.30$4.85-0.4011534%53.7%17.6%27
Dec 18, 202685.00$2.95$3.43-0.348734%62.5%16.9%129
Feb 19, 202787.50$5.10$5.75-0.4015034%53.2%16.0%1
Nov 20, 202682.50$1.85$2.10-0.265934%74.2%15.7%94
Jan 15, 202785.00$3.30$3.85-0.3411534%60.9%14.4%471

As of September 25, 2026

Run the Wheel on EW With Confidence

Find the best EW wheel strategy setups across strikes and expirations, plan ahead with at-strike values, and keep your covered calls and puts on track.

Start your 14-day free trial